IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
about
Immune complexes as therapy for autoimmunityThe antiinflammatory activity of IgG: the intravenous IgG paradoxTargeting the Fc receptor in autoimmune diseaseTetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia.Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.Fc receptors in immune thrombocytopenias: a target for immunomodulation?Mechanisms of action of intravenous immunoglobulins.IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.Intravenous immunoglobulin does not increase FcγRIIB expression levels on monocytes in children with immune thrombocytopenia.B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo.Cellular immune dysfunction in immune thrombocytopenia (ITP).Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.Fcγ receptor expression on splenic macrophages in adult immune thrombocytopenia.Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis.Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.Polymeric human Fc-fusion proteins with modified effector functions.Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.Low-affinity Fcgamma receptors, autoimmunity and infection.FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.Novel roles for the IgG Fc glycan.FcγRIIB: a modulator of cell activation and humoral tolerance.The role of sialic acid as a modulator of the anti-inflammatory activity of IgG.The function of Fcγ receptors in dendritic cells and macrophages.Type I and type II Fc receptors regulate innate and adaptive immunity.Do immune complexes play a role in hemolytic sequelae of intravenous immune globulin?Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection.Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis.Sweet SIGNs: IgG glycosylation leads the way in IVIG-mediated resolution of inflammation.Natural autoantibodies: immune homeostasis and therapeutic interventionMolecular and Cellular Pathways of Immunoglobulin G Activity In Vivo
P2860
Q24558642-848E5525-CA17-4C6D-B407-BA69B6417261Q24676548-2DD79BB2-DF6E-40C5-B29D-8A8ECA117AFBQ27002843-B54EA821-9A16-467A-A59F-3A02CD093A34Q33362763-F75B4BDA-FD87-42BB-9863-30B7E0E4837AQ33364381-79B7AA0F-8E84-4829-99B1-50667698B069Q33364630-8624E5C8-EC90-4604-AED2-00D45A1710B5Q33371273-E887069B-7A77-406D-80F3-63B43CDBAFBDQ33372342-28568CAC-2EDD-46F2-91D4-C8EB90765B91Q33380494-240A732A-24D7-4778-A146-FF3AA4F426E4Q33389428-AEC7F8A0-AE6D-4D2E-8C23-875F5FBECBC8Q33399346-7561656B-978C-4D38-8784-8CA94D9B28F2Q33401630-A133E52E-E47B-4F54-A832-00ECAB5E924FQ33401632-3FBE2D54-5911-495A-8E7C-522A8A2FD100Q33403107-28424A0F-0ED6-416D-A481-24B73D59C97EQ33409710-E3A80877-1BE6-40BA-8737-3867F0B2657EQ33415298-DD82D28D-E06A-4E7A-BA18-8EFCCAD28211Q33419269-6EEBC1DF-9A55-43F1-9D8A-F61A94E8B096Q33420853-3CAC265E-BCE5-4136-9037-0D8709384890Q33438855-DD42D3AA-FFFA-492D-B12D-56F59FDA5768Q33926907-E917829D-5A2C-4FF7-9A71-C3B058FE4AD5Q33981829-96AEB688-4F24-4928-99B1-4E82FFF58F95Q35551564-79845DEC-9905-49CB-8457-B3B0460951E3Q36066311-D0D1BB40-2113-466A-B4FE-C3E190E96581Q37578785-5D198BFC-BF3D-4853-BCD9-F0046D7A7700Q37736263-713D2C08-1270-4742-82C4-5C6921FB14FAQ37979848-20AE26D9-8C70-4A50-BCC3-B08DDCD90C30Q37990547-D91F7497-0796-4027-BD58-29A1A77C8C33Q37995919-6FAA86B5-46FD-44A0-A452-E73AEA6A6B34Q38180345-26876B7D-2B44-4554-952B-F4C4A5E125FBQ38232105-7213F9A4-77B2-43D3-B1D2-A595892A373AQ38547198-2F8E7A57-0AF2-4391-B50E-083B7C1267E7Q42375731-165BC866-2108-4620-8A57-9E711A7689CAQ47550160-14CD394B-5A55-4715-81A2-F91648EBC4C4Q48180643-C330BF28-E23F-4435-B1CE-A767878DDFAEQ50193260-3277F5C3-DD6F-451C-BDEE-D302282B12A0Q58864672-BF8FA242-E9B0-4EA3-A0FA-14D7051A6B41Q59047780-A7051976-044F-466D-B4D5-E3EF2D274C67
P2860
IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@ast
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@en
type
label
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@ast
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@en
prefLabel
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@ast
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@en
P2093
P1433
P1476
IVIg-mediated amelioration of ...... HIP1, SHP-1, and Btk activity.
@en
P2093
Cheryl D Helgason
John Freedman
Katherine A Siminovitch
R Keith Humphries
P304
P356
10.1182/BLOOD-2003-01-0023
P407
P577
2003-03-20T00:00:00Z